Prognostic factors for treated canine malignant lymphoma

Veterinary Pathology

Volumn 36, Issue 4, 1999, Pages 292-300

  Kiupel, M ^a,d,e   Teske, E ^b   Bostock, D ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d PURDUE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

Argyrophil nucleolar organizer region; Canine malignant lymphoma, immunophenotype; Ki 67 monoclonal antibody; Prognostic factors; Proliferation cell nuclear antigen

Indexed keywords

CANIS FAMILIARIS;

ANTINEOPLASTIC AGENT; CYCLINE;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; DOG; DOG DISEASE; FEMALE; LYMPHOMA; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SURVIVAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; FEMALE; LYMPHOMA; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL ANALYSIS;

EID: 0033159782     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.36-4-292     Document Type: Article

References (45)

1. Appelbaum FR, Sale GE, Storb R. Charrier K, Deeg HJ, Graham TC, Wulff JC: Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy. Haematol Oncol 2:151-167, 1984
2. Bostock DE, Crocker J, Harris K, Smith P: Nucleolar organizer regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours, Br J Cancer 59:915-918, 1989
3. Bravo R, Frank R, Blundell PA, McDonald BH: Cycline/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515-517, 1987
4. Brugal G: Interpretation of proliferation markers. Comp Cytol Histol Labor 234-239, 1994
5. Busch H, Lischwe MA, Michalik J, Chan PK, Busch R: Nucleolar proteins of special interest: silver-staining proteins B23 and C23 and antigens of human tumor nucleoli. In: The Nucleolus, ed. Jordan EG, and Cullis CA, pp. 43-72. Cambridge University Press, London, UK, 1984
6. Capurro C, Buracco P, Rossi L: Lymphoma in dogs. Veterinaria 4:15-27, 1990
7. Carter RF, Valli VEO, Lumsden JH: The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute working formulation, Can J Vet Res 50:154-164, 1986
8. Cotter SM: Treatment of lymphoma and leukemia with cyclophosphamide, vincristine and prednisolone. I. Treatment of dogs. J Am Anim Hosp Assoc 23:159-172, 1983
9. Crocker J: Nucleolar organizer regions. Curr Top Pathol 82:91-143, 1990
10. Crocker J, Boldy D, Egan MJ: How should we count AgNORs? Proposals for a standardized approach. J Pathol 158:185-188, 1989
11. Crocker J, Egan MJ: Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas. J Pathol 156: 233-239, 1988
12. Crocker J, Nar P: Nucleolar organizer regions in lymphomas. J Pathol 151:111-118, 1987
13. Derenzini M, Pession A, Trere D: The quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest 63:137-140, 1990
14. Derenzini M, Trere D: Importance of interphase nucleolar organizer regions in tumour pathology. Virchows Arch B 61:1-8, 1991
15. Derenzini M, Trere D: AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralbl Pathol 140: 7-10, 1994
16. Dorn CR, Taylor DON, Hibbard HH: Epizootiologic characteristics of canine and feline leukemia and lymphoma. Am J Vet Res 28:993-1001, 1967
17. Field DH, Fitzgerald PH, Sin FY: Nucleolar silver-staining patterns related to cell cycle phase and cell generation of PHA-stimulated human lymphocytes. Cytobios 41:23-33, 1984
18. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873, 1991
19. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Malus RE, Kimmel M, Hurvitz AI, Liebermann PH: Lymphomas in dogs. A morphologic, immunologic and clinical study. Cancer 66:480-491, 1990
20. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG: The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J Pathol 154:223-231, 1988
21. Hansen AB, Ostergard B: Nucleolar organizer regions in hyperplastic and neoplastic prostatic tissue. Virchows Arch A 147:9-13, 1990
22. Hufnagel P, Guski H, Schulz HJ: Measuring of AgNORs using image analysis. Zentralbl Pathol 140:31-35, 1994
23. Jakijc-Razumovijc J, Tentor D, Petroveicki M, Radman I: Nucleolar organizer regions and survival in patients with non-Hodgkin's lymphomas classified by the Working Formulation. J Clin Pathol 46:943-947, 1993
24. Jan-Mohamed RM, Murray PG, Crocker J, Leyland MJ: Sequential demonstration of nucleolar organizer regions and Ki-67 immunolabelling in non-Hodgkin's lymphomas. Clin Lab Haematol 12:395-399, 1990
25. Kalir T, Chan KS, Liu Z, Strauchen J, Gil J: Semi-automatic quantitation of nucleolar organizer regions in non-Hodgkin's lymphomas. Pathol Res Pract 190:124-128, 1994
26. Kirn I, Park SH, Paik SY: Nucleolar organizer regions of lymphomas in Korea. J Korean Med Sci 3:99-105, 1988
27. Kiupel M, Bostock DE, Bergmann V: A semiquantitative method for the evaluation of AgNORs in canine malignant lymphomas. Eur J Vet Pathol 4:67-71, 1998
28. Kiupel M, Bostock DE, Bergmann V: The prognostic significance of AgNOR-and PCNA-counts and histopathological grading of canine malignant lymphomas. J Comp Pathol 119:407-418, 1998
29. Lennert K, Feller AC: Histopathologie der Non-Hodgkin-Lymphome, 2nd ed. Springer Verlag, Berlin, Germany, 1990
30. Lennert K, Mohri N: Malignant Lymphomas other than Hodgkin's Disease: Histopathology and Diagnosis of Non-Hodgkin's Lymphomas. Springer Verlag, New York, NY, 1978
31. Loehr CV, Teifke JP, Failing K, Weiss E: Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 34:212-221, 1997
32. MacEwen EG, Rosenthal RC, Fox LE, Loar AS, Kurzman ID: Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double blind study in canine lymphoma. J Vet Intern Med 6:230-234, 1992
33. Munakata S, Hendricks JB: Morphometric analysis of AgNORs in imprints and sections from non-Hodgkin's lymphomas. An approach to standardization. Anal Quant Cytol Histol 15:329-334, 1993
34. National Cancer Institut: The non-Hodgkin's lymphoma pathologic classification project: National Cancer Institut sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
35. Owen LN, ed.: TNM Classification of Tumours in Domestic Animals, pp. 46-47. World Health Organization. Geneva, Switzerland, 1980
36. Parodi AL, Dargent F, Crespeau F: Histological classification of canine malignant lymphomas. J Vet Med A 35: 178-192, 1988
37. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ: Improvement in the staining and in the argyrophilic protein of the nucleolar organizer region at the optical level. Histochem J 18:5-14, 1986
38. Rüschoff J: Nukleolus organisierende Regionen (NORs) in der pathomorphologischen Tumordiagnostik. Fischer Verlag, Stuttgart, Germany, 1992
39. Rüschoff J, Fauser G, Knüchel R. Hofstädter F: AgNOR quantification with special reference to staining patterns. Zentralbl Pathol 140:23-30, 1994
40. Simoes JPC, Schoning P, Butine M: Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 31:637-647, 1994
41. Teske E, van Heerde P, Rutteman GR, Kurzman I, Moore PF, MacEwen EG: Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 205: 1722-1728, 1994
42. Teske E, Wisman P, Moore PF. van Heerde P: Histological classification and immunophenotyping of canine non-Hodgkin's lymphoma. Unexpected high frequency of T-cell lymphomas with B-cell morphology. Exp Hematol 22:1179-1187, 1994
43. Trere D: AgNOR quantification in tumor pathology: what is actually evaluated? Anat Cell Pathol 5:191-201, 1993
44. Vail DM, Kisseberth WC, Obradivich JE, Moore FM, London CA, MacEwen EG, Ritter MA: Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Exp Hematol 24:807-815, 1996
45. Yekeler H, Ozercan MR, Yumbul AZ, Ajgan M, Ozercan IH: Nucleolar organizer regions in lymphomas: a quantitative study. Pathologica 85:353-362, 1993